Zeke Capital Advisors, LLC Novartis Ag Transaction History

Zeke Capital Advisors, LLC

$1.53 Billion
Q4 2022

A detailed history of Zeke Capital Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 50,236 shares of NVS stock, worth $4.95 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

50,236

Previous 59,610 15.73%

Holding current value

$4.95 Million

Previous $4.53 Million 0.57%

% of portfolio

0.3%

Previous 0.33%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $708,205 - $867,282	-9,374 Reduced 15.73%	50,236 $4.56 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $2,089 - $2,443	-28 Reduced 0.05%	59,610 $4.53 Million
Q2 2022 Aug 09, 2022	BUY	$80.52 - $93.75 $472,491 - $550,125	5,868 Added 10.91%	59,638 $5.04 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $451,900 - $511,187	5,641 Added 11.72%	53,770 $4.72 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $378,734 - $418,793	4,752 Added 10.96%	48,129 $4.21 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $53,811 - $62,602	-658 Reduced 1.49%	43,377 $3.55 Million
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $40,233 - $44,438	472 Added 1.08%	44,035 $4.02 Million
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $2.24 Million - $2.71 Million	28,735 Added 193.79%	43,563 $4.11 Million
Q3 2020 Nov 09, 2020	SELL	$82.14 - $91.0 $12,731 - $14,105	-155 Reduced 1.03%	14,828 $1.29 Million
Q2 2020 Jul 21, 2020	SELL	$80.93 - $91.1 $110,793 - $124,715	-1,369 Reduced 8.37%	14,983 $1.31 Million
Q1 2020 Apr 24, 2020	SELL	$70.67 - $99.01 $2.34 Million - $3.28 Million	-33,109 Reduced 66.94%	16,352 $1.35 Million
Q4 2019 Jan 17, 2020	BUY	$84.35 - $95.37 $39,897 - $45,110	473 Added 0.97%	49,461 $4.68 Million
Q3 2019 Oct 18, 2019	BUY	$85.54 - $94.26 $33,446 - $36,855	391 Added 0.8%	48,988 $4.26 Million
Q2 2019 Jul 24, 2019	BUY	$75.4 - $92.8 $41,771 - $51,411	554 Added 1.15%	48,597 $4.44 Million
Q1 2019 Apr 29, 2019	BUY	$75.32 - $86.15 $69,143 - $79,085	918 Added 1.95%	48,043 $4.62 Million
Q4 2018 Feb 11, 2019	SELL	$73.66 - $82.02 $232,839 - $259,265	-3,161 Reduced 6.29%	47,125 $4.04 Million
Q3 2018 Nov 08, 2018	BUY	$66.94 - $77.43 $94,318 - $109,098	1,409 Added 2.88%	50,286 $4.33 Million
Q2 2018 Jul 24, 2018	BUY	$64.91 - $73.36 $2.88 Million - $3.26 Million	44,429 Added 998.85%	48,877 $3.69 Million
Q1 2018 May 03, 2018	SELL	$70.39 - $84.15 $11,755 - $14,053	-167 Reduced 3.62%	4,448 $360,000
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $140,464 - $150,776	1,942 Added 72.65%	4,615 $387,000
Q3 2017 Nov 09, 2017	BUY	$74.14 - $77.27 $198,176 - $206,542	2,673	2,673 $229,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.

Account

Zeke Capital Advisors, LLC Novartis Ag Transaction History